Measles-related hospitalizations and complications in Japan, 2007-2008

Internal Medicine

Volumn 49, Issue 18, 2010, Pages 1965-1970

  Yasunaga, Hideo ^a   Shi, Yongjin ^a   Takeuchi, Masato ^b   Horiguchi, Hiromasa ^a   Hashimoto, Hideki ^c   Matsuda, Shinya ^d   Ohe, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO METROPOLITAN POLICE HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Complications; Diagnosis procedure combination; Encephalitis; Length of stay; Measles; Pneumonia

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL FEATURE; CONJUNCTIVITIS; CONTROLLED STUDY; DISEASE SEVERITY; ENCEPHALITIS; ENTEROPATHY; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEASLES; MEDICAL RECORD; MENINGITIS; OTITIS MEDIA; PNEUMONIA; PREGNANCY; PREGNANT WOMAN; SEX RATIO; SPONTANEOUS ABORTION; STILLBIRTH;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; JAPAN; MALE; MEASLES; MIDDLE AGED; OTITIS MEDIA; PNEUMONIA, VIRAL; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77957936483     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3843     Document Type: Article

References (31)

1. Asaria P, MacMahon E. Measles in the United Kingdom: can we eradicate it by 2010? BMJ 333: 890-895, 2006.
2. Duke T, Mgone CS. Measles: not just another viral exanthema. Lancet 361: 763-773, 2003.
3. Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis 189: S4-S16, 2004.
4. Ciofi degli Atti ML, Filia A, Massari M, et al. Assessment of measles incidence, measles-related complications and hospitalisations during an outbreak in a southern Italian region. Vaccine 24: 1332-1338, 2006.
5. Van Den Hof S, Smit C, Van Steenbergen JE, De Melker HE. Hospitalizations during a measles epidemic in the Netherlands, 1999 to 2000. Pediatr Infect Dis J 21: 1146-1150, 2002.
6. World Health Organization Europe. Eliminating measles and rubella and preventing congenital rubella infection. WHO European region strategic plan 2005-2010. WHO Regional Office for Europe, Copenhagen, 2005: 1-34.
7. Gomi H, Takahashi H. Why is measles still endemic in Japan? Lancet 64: 328-329, 2004.
8. Centers for Disease Control and Prevention. Progress toward measles elimination-Japan, 1999-2008. MMWR Morb Mortal Wkly Rep 57: 1049-1052, 2008.
9. Kaetsu A, Miyazaki M, Imatoh T, et al. An outbreak of measles in Saitama City in 2007. What is the vaccination strategy to eliminate measles in Japan? Journal of Infection and Chemotherapy 14: 291-295, 2008.
10. Nagano H, Jinushi M, Tanabe H, Yamaguchi R, Okano M. Epidemiological and molecular studies of measles at different clusters in Hokkaido district, Japan, 2007. Japanese Journal of Infectious Diseases 62: 209-211, 2009.
11. Infectious Disease Surveillance Center. Statistics on the occurrence of measles (http://idsc.nih.go.jp/disease/measles/03.html) [in Japanese] Accessed on June 8, 2010.
12. Kuwabara K, Matsuda S, Imanaka Y, et al. Injury severity score, resource use, and outcome for trauma patients within a Japanese administrative database. J Trauma 68: 463-470, 2010.
13. Yasunaga H, Yanaihara H, Fuji K, Horiguchi H, Hashimoto H, Matsuda S. Impact of hospital volume on postoperative complications and in-hospital mortality after renal surgery: data from the Japanese Diagnosis Procedure Combination Database. Urology 2010 May 6 [Epub ahead of print].
14. Filia A, Brenna A, Pana A, Cavallaro GM, Massari M, Colfi degli Atti ML. Health burden and economic impact of measles-related hospitalizations in Italy in 2002-2003. BMC Public Health 7: 169, 2007.
15. Takayama N, Suganuma A. Clinical investigation on adult inpatients contracted measles; comparing with pediatric measles inpatients. Kansenshogaku Zasshi (Journal of the Japanese Association for Infectious Diseases) 77: 815-821, 2003 (in Japanese, Abstract in English).
16. Yamauchi H, Yumoto M, Tanahashi J, Miura M, Nakamura F, Katsuya H. Three cases of adult measles encephalitis. ICU&CCU (Japanese Journal of Intensive Care Medicine) 28: 59-64, 2004 (in Japanese, Abstract in English).
17. Caceres VM, Strebel PM, Sutter RW. Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis 31: 110-119, 2000.
18. Davidkin I, Valle M. Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts. Vaccine 16: 2052-2057, 1998.
19. Lee M, Chien L, Yueh Y, Lu C. Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995-1997. Vaccine 19: 4644-4651, 2001.
20. Ihara T. The strategy for prevention of measles and rubella prevalence with measles-rubella (MR) vaccine in Japan. Vaccine 27: 3234-3236, 2009.
21. Ueda K, Miyazaki C, Hidaka Y, Okada K, Kusuhara K, Kadoya R. Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan. Lancet 346: 701-702, 1995.
22. Atmar RL, Englund JA, Hammill H. Complications of measles during pregnancy. Clin Infect Dis 14: 217-226, 1992.
23. Eberhart-Phillips JE, Frederick PD, Baron RC, Mascola L. Measles in pregnancy: a descriptive study of 58 cases. Obstet Gynecol 82: 797-801, 1993.
24. Aaby P, Bukh J, Lisse IM, Seim E, de Silva MC. Increased perinatal mortality among children of mothers exposed to measles during pregnancy. Lancet 331: 516-519, 1988.
25. Hackley BK. Immunizations in pregnancy. A public health perspective. J Nurse-Midwifery 44: 106-117, 1999.
26. Kaplan LJ, Daum RS, Smaron M, McCarthy CA. Severe measles in immunocompromised patients. JAMA 267: 1237-1241, 1992.
27. Arrowood JR, Hayney MS. Immunization recommendations for adults with cancer. Annal Pharmacother 36: 1219-1229, 2002.
28. Feldman S, Andrew M, Norris M, McIntyre B, Iyer R. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia. Clin Infect Dis 27: 388-390, 1998.
29. Zignol M, Peracchi M, Tridello G, et al. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer 101: 635-641, 2004.
30. Johnson RT, Griffin DF, Hirsh RL, et al. Measles encephalomyelitis- clinical and immunological studies. N Engl J Med 310: 137-141, 1984.
31. Hosoya M. Measles encephalitis: direct viral invasion or autoimmune- mediated inflammation? Intern Med 45: 841-842, 2006.